This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Berraondo, P. Articles by Leclerc, C. Search for Related Content PubMed PubMed Citation Articles by Berraondo, P. Articles by Leclerc, C.

Eradication of Large Tumors in Mice by a Tritherapy Targeting the Innate, Adaptive, and Regulatory Components of the Immune System

¹ Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie; ² Institut National de la Sante et de la Recherche Medicale, U883; ³ Institut Pasteur, Unité de Biochimie des Interactions Macromoléculaires, Centre National de la Recherche Scientifique URA 2185, Paris, France; and ⁴ BT PHARMA S.A., Labège, France

Requests for reprints: Claude Leclerc, Unité de Régulation Immunitaire et Vaccinologie, Institut National de la Sante et de la Recherche Medicale, U883, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris Cedex 15, France. Phone: 33(0)1-45-68-86-18; Fax: 33(0)1-45-68-85-40; E-mail: cleclerc{at}pasteur.fr.

Targeting the human papillomavirus (HPV) E7 antigen to dendritic cells with the adenylate cyclase (CyaA) of Bordetella pertussis as a vaccine vector led to potent therapeutic immune responses against TC-1 tumors in a murine model of cervical carcinoma induced by HPV. However, as the time between tumor graft and vaccination increased, the antitumor efficacy of the CyaA-E7 vaccine gradually decreased. The vaccine had no effect if the tumor diameter was >8 mm. Analyses of regulatory cells recruited during TC-1 tumor growth revealed a high number of splenic MDSCs and a large percentage of regulatory T cells, particularly in the tumor. Administration of a tritherapy including CpG complexed with a cationic lipid, low-dose cyclophosphamide, and the CyaA-E7 vaccine completely overcame tumor-associated immunosuppression and eradicated large, established tumors in almost all treated animals. This strong antitumor response was followed by a large expansion of regulatory T cells in tumor, spleen, and tumor-draining lymph nodes and of splenic neutrophils. These findings indicate that immunotherapeutic strategies that simultaneously target innate, adaptive, and regulatory components of the immune system are effective in the eradication of large tumors. [Cancer Res 2007;67(18):8847–55]